Pfizer Sees Once Daily Danuglipron In The “Reasonable Future”

 
• By Jessica Merrill
scale
Pfizer updated investors on its GLP-1 agonist for weight loss • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapeutic Category